Paul Tudor Jones’s Apexigen, Inc. Common Stock APGN Stock Holding History

Paul Tudor Jones’s Portfolio APGN Stock Details APGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-89,746	Closed	-$912K	–	2826
2022 Q2	$912K	Sell	89,746 -12,254	-12%	-$124K	0.02%	945
2022 Q1	$1.03M	Sell	102,000 -98,000	-49%	-$983K	0.02%	906
2021 Q4	$2M	Hold	200,000	–	–	0.03%	622
2021 Q3	$1.99M	Hold	200,000	–	–	0.03%	706
2021 Q2	$1.99M	Hold	200,000	–	–	0.04%	567
2021 Q1	$1.97M	Buy	+200,000	New	+$2M	0.04%	529

Other funds holding APGN

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Yu Fan $108M AUM 137.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Paul Tudor Jones's APGN Position: Q3 2022 in Review

Paul Tudor Jones sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2022, closing a stake of 89,746 shares — an estimated $912K sold.

Paul Tudor Jones first reported a position in APGN in Q1 2021 and held it in 6 quarters. The position peaked at $2M in Q4 2021. 18 funds tracked by Wall St. Rank hold APGN as of Q3 2022.

Paul Tudor Jones reported no remaining Apexigen, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Paul Tudor Jones sold 89,746 Apexigen, Inc. Common Stock shares in Q3 2022, an estimated $912K.
Paul Tudor Jones first reported a position in Apexigen, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
Paul Tudor Jones's Apexigen, Inc. Common Stock position peaked at $2M in Q4 2021.
18 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2022.

Based on Tudor Investment Corp's 13F filing for Q3 2022, filed 14 Nov 2022.